18. Estrategias y ejemplos de diseños de novo. Inhibidores de la proteasa del virus del SIDA. Inhibidores poliamídicos específicos de genes.

Bibliografía:

• Structure-based thermodynamic design of peptide ligands: application to peptide inhibitors of the aspartic protease endothiapepsin. Luque, I., Gómez, J., Semo, N., & Freire, E. Proteins (1998) 30:74-85. (pedido)

• Structure-based drug design: computational advances. Marrone, TJ, Briggs, JM, McCammon, JA. Annu. Rev. Pharmacol. Toxicol. (1997) 37:71-90.(pedido)

• Inhibitors of HIV-1 protease: a major success of structure-assisted drug design. Annu. Rev. Biophys. Biomol. Struct. (1998) 27:249-284.(pedido)

• Drug-DNA interactions. Chaires, J.B. COSB (1998) 8:314-320.

• Regulation of gene expression by small molecules. Nature (1997) 387:202-205.

• Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. P.Y.S. Lam et al. Science (1994) 263: 380-384

• Structure-based discovery of inhibitors of thymidylate synthase. B.K. Schoichet, R.M. Stroud, D.V. Santi, I.D. Kuntz, K.M. Perry. Science 259:1445-1450.